Gilad Almogy, Ultima Genomics CEO

Bay Area ge­nomics start­up emerges from stealth with $600M in the bank and promis­ing a '$100 genome' test

When talk­ing about ge­nomics biotechs, fi­nanc­ing rounds tend to be more on the mod­est side — an $18.5 mil­lion Se­ries A round for one, …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.